{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:20:13Z","timestamp":1794486013889,"version":"4.9.1"},"reference-count":29,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Patients with central nervous system germ cell tumours (CNS-GCTs) commonly initially present to primary care or general paediatricians. Prolonged symptom intervals (SI) are frequently seen in CNS-GCTs and have been associated with inferior outcomes in other brain tumours. This study reviewed the clinical presentation of CNS-GCTs and examined the effect of prolonged SI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design\/Setting\/Patients\/Outcomes<\/jats:title><jats:p>International multicentre 10-year retrospective study (2002\u20132011 inclusive), across six international paediatric oncology treatment centres. All newly diagnosed patients with CNS-GCT were included. Main outcome measure was time interval from first symptom to diagnosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study cohort included 86 (58 males:28 female) patients (59 \u2018germinoma\u2019 and 27 \u2018non-germinomatous\u2019 GCTs), with tumours being pineal (n=33), suprasellar (n=25), bifocal (pineal+suprasellar; n=24) and \u2018other\u2019 site (n=4), of which 16 (19%) were metastatic. Median age at diagnosis was 14 years (0\u201323 years). The time to diagnosis from first symptom (SI) was 0\u201369 months (median 3\u2009months, mean 9\u2009months). A prolonged SI (&gt;6 months) was observed in 28\/86 patients (33%) and significantly associated with metastatic disease (11\/28 (39%) vs 5\/58 (9%); p=0.002)) at diagnosis, but not overall survival. With prolonged SI, endocrine symptoms, particularly diabetes insipidus, were more common (21\/28 (75%) vs 14\/58 (24%) patients; p&lt;0.002), but raised intracranial pressure (RICP) was less frequent (4\/28 (14%) vs 43\/58 (74%) patients; p&lt;0.001)) at first symptom.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>One-third of patients with CNS-GCT have &gt;6\u2009months of symptoms prior to diagnosis. Delayed diagnosis is associated with metastatic disease. Early symptom recognition, particularly related to visual and hormonal disturbances in the absence of RICP, may improve timely diagnosis, reduce metastatic disease frequency and consequently reduce treatment burden and late effects.<\/jats:p><\/jats:sec>","DOI":"10.1136\/archdischild-2019-317245","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T21:25:11Z","timestamp":1570569911000},"page":"247-252","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["Symptom interval and treatment burden for patients with malignant central nervous system germ cell tumours"],"prefix":"10.1136","volume":"105","author":[{"given":"James","family":"Hayden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4480-1147","authenticated-orcid":false,"given":"Matthew J","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thankamma","family":"Ajithkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brinda","family":"Muthusamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Penn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Calaminus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,10,8]]},"reference":[{"key":"2021052401051240000_105.3.247.1","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1177\/0883073818772470","article-title":"Central nervous system germ cell tumors: a review of the literature","volume":"33","author":"Kong","year":"2018","journal-title":"J Child Neurol"},{"issue":"Suppl 5","key":"2021052401051240000_105.3.247.2","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/nos218","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009","volume":"14 Suppl 5","author":"Dolecek","year":"2012","journal-title":"Neuro Oncol"},{"key":"2021052401051240000_105.3.247.3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11060-014-1562-7","article-title":"Incidence of intracranial germ cell tumors by race in the United States, 1992-2010","volume":"120","author":"Poynter","year":"2014","journal-title":"J Neurooncol"},{"key":"2021052401051240000_105.3.247.4","unstructured":"Parkin D , Kramarova E , Draper G , et al . International incidence of childhood cancer(Volume II), 1998."},{"key":"2021052401051240000_105.3.247.5","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2008-0037"},{"key":"2021052401051240000_105.3.247.6","doi-asserted-by":"crossref","first-page":"494","DOI":"10.4143\/crt.2016.129","article-title":"Nationwide population-based incidence and survival rates of malignant central nervous system germ cell tumors in Korea, 2005-2012","volume":"49","author":"Lee","year":"2017","journal-title":"Cancer Res Treat"},{"key":"2021052401051240000_105.3.247.7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/apm.1965.64.4.407","article-title":"Classification of endodermal sinus tumour (mesoblatoma vitellinum) and so-called \"embryonal carcinoma\" of the ovary","volume":"64","author":"Teilum","year":"1965","journal-title":"Acta Pathol Microbiol Scand"},{"key":"2021052401051240000_105.3.247.8","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2388(199903)16:2<144::AID-SSU6>3.0.CO;2-M"},{"key":"2021052401051240000_105.3.247.9","first-page":"7268","article-title":"Multipoint imprinting analysis indicates a common precursor cell for gonadal and nongonadal pediatric germ cell tumors","volume":"61","author":"Schneider","year":"2001","journal-title":"Cancer Res"},{"key":"2021052401051240000_105.3.247.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.2007.00793.x"},{"key":"2021052401051240000_105.3.247.11","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/not019"},{"key":"2021052401051240000_105.3.247.12","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/neuonc\/nox122","article-title":"Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial","volume":"19","author":"Calaminus","year":"2017","journal-title":"Neuro Oncol"},{"key":"2021052401051240000_105.3.247.13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.clon.2018.01.009","article-title":"Current management of intracranial germ cell tumours","volume":"30","author":"Bowzyk Al-Naeeb","year":"2018","journal-title":"Clin Oncol"},{"key":"2021052401051240000_105.3.247.14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.5132"},{"key":"2021052401051240000_105.3.247.15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11060-006-9282-2","article-title":"Epidemiological survey of central nervous system germ cell tumors in Canadian children","volume":"82","author":"Keene","year":"2007","journal-title":"J Neurooncol"},{"key":"2021052401051240000_105.3.247.16","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1997.86.3.0446"},{"key":"2021052401051240000_105.3.247.17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/0284186X.2011.586000","article-title":"Intracranial germ cell tumours. A review with special reference to endocrine manifestations","volume":"51","author":"Jorsal","year":"2012","journal-title":"Acta Oncol"},{"key":"2021052401051240000_105.3.247.18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2002.01620.x"},{"key":"2021052401051240000_105.3.247.19","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000261908.36803.ac"},{"key":"2021052401051240000_105.3.247.20","unstructured":"Klitbo DM , Nielsen R , Illum NO , et al . Symptoms and time to diagnosis in children with brain tumours. Dan Med Bull 2011;58:A4285."},{"key":"2021052401051240000_105.3.247.21","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.jpeds.2013.06.024","article-title":"Delayed diagnosis in children with intracranial germ cell tumors","volume":"163","author":"Sethi","year":"2013","journal-title":"J Pediatr"},{"key":"2021052401051240000_105.3.247.22","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-011-1480-z"},{"key":"2021052401051240000_105.3.247.23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00381-011-1564-0","article-title":"Diagnostic delay of pediatric brain tumors in Israel: a retrospective risk factor analysis","volume":"28","author":"Shay","year":"2012","journal-title":"Childs Nerv Syst"},{"key":"2021052401051240000_105.3.247.24","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00381-013-2164-y","article-title":"Latency of intracranial germ cell tumors and diagnosis delay","volume":"29","author":"Phi","year":"2013","journal-title":"Childs Nerv Syst"},{"key":"2021052401051240000_105.3.247.25","doi-asserted-by":"crossref","first-page":"e472","DOI":"10.1016\/j.wneu.2018.10.082","article-title":"Delays in diagnosis of pediatric histologically confirmed sellar germ cell tumors in China: a retrospective risk factor analysis","volume":"122","author":"Zhang","year":"2019","journal-title":"World Neurosurg"},{"key":"2021052401051240000_105.3.247.26","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nov187"},{"key":"2021052401051240000_105.3.247.27","doi-asserted-by":"publisher","DOI":"10.1177\/088307389501000308"},{"key":"2021052401051240000_105.3.247.28","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-011-1485-7"},{"key":"2021052401051240000_105.3.247.29","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2217\/cns.13.36","article-title":"Strategies to accelerate diagnosis of primary brain tumors at the primary-secondary care interface in children and adults","volume":"2","author":"Walker","year":"2013","journal-title":"CNS Oncol"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2019-317245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T08:07:11Z","timestamp":1621843631000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2019-317245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,8]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,2,20]]},"published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.1136\/archdischild-2019-317245"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2019-317245","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,8]]}}}